Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)
Breast Cancer, Cancer of the Breast
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring prehabilitation, physical activity, cancer-related cognitive decline, telehealth, physical therapy, survivorship, breast cancer
Eligibility Criteria
Eligibility Criteria: Diagnosis of breast cancer (stage I-III). Female. At least 18 years old. Scheduled to receive curative-intent chemotherapy. English speaking. Deemed fit to participate in a PA intervention by their oncologist. Not currently participating in another physical activity research study. Low active, defined by self-report as no more than 2 times per week of regular physical activity in the last six months Able to understand and willing to sign an IRB-approved written informed consent document.
Sites / Locations
- Washington University School of MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Physical Activity Intervention
Usual care, wait-list control condition
Participants will complete a primarily home-based PA intervention, with the goal of safely increasing their steps/day by incorporating moderate-to-vigorous physical activity (MVPA) Participants will receive Fitbits with heart rate capabilities to support maintenance of the prescribed intensity during home exercise sessions and participants' self-monitoring of daily steps. Participants will strategize aerobic MVPA behaviors with the intervention PT to identify preferable and enjoyable PA modalities (e.g., walking, cycling), while also identifying alternative options to allow for flexibility if life- or cancer-specific barriers arise During the first Zoom coaching session, the intervention PT will train participants on using the Fitbit and completing home exercise logs. The PT will continue to meet with participants to support exercise maintenance, review home exercise sessions, strategize new exercises, and troubleshoot emerging chemotherapy-related health declines.
-Participants in the control group will proceed with their treatment regimen as prescribed by their oncologist(s). To prevent drop out and high attrition rates as well as promote healthy behavior, control group participants will receive a Fitbit at the initial set-up meeting to wear during chemotherapy, as well as an individualized home exercise program and up to two Zoom coaching sessions with a PT after chemotherapy completion.